Literature DB >> 3510060

Reduction by the gut microflora of animals and man.

I R Rowland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3510060     DOI： 10.1016/0006-2952(86)90550-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.

Authors:  K Mross; U Mayer; K Hamm; K Burk; D K Hossfeld
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The metabolism of drugs by the gut flora.

Authors:  M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

Review 3.  Age-related changes in the gastrointestinal system. Effects on drug therapy.

Authors:  F L Iber; P A Murphy; E S Connor
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

4.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

5.  Bioconversion of netobimin pro-drug by gastrointestinal fluids of ruminants.

Authors:  C E Lanusse; B Nare; L H Gascon; R K Prichard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Apr-Jun       Impact factor: 2.441

6.  Influence of diet on the pattern of gastrointestinal biotransformation of netobimin and albendazole sulphoxide in sheep.

Authors:  G Virkel; A Lifschitz; A Pis; C Lanusse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.569
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.